Trials / Unknown
UnknownNCT05528393
Prolactin and FGF21 in Gestational Diabetes Mellitus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Shen Qu · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Prolactin (PRL) and PRL receptor (PRLR) signaling has been validated to play an important role in the modulation of glucolipid metabolism. However, the role of serum PRL levels in gestational diabetes mellitus (GDM) remains unclear. The investigators aimed to explore the possible influence of serum PRL within or without normal range on the development of GDM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sampling | blood sampling |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-09-01
- Completion
- 2022-12-01
- First posted
- 2022-09-06
- Last updated
- 2022-09-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05528393. Inclusion in this directory is not an endorsement.